New antineoplastic agents in lung cancer 1988-1993.
Grant
S C
SC
Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
Kris
M G
MG
D000630:Aminopterin / Q000031:analogs & derivatives / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002166:Camptothecin / Q000031:analogs & derivatives / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy; D018288:Carcinoma, Small Cell / Q000188:drug therapy; D002986:Clinical Trials as Topic; D006801:Humans; D000077146:Irinotecan; D008175:Lung Neoplasms / Q000188:drug therapy*; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D009943:Organophosphorus Compounds / Q000627:therapeutic use; D017239:Paclitaxel / Q000627:therapeutic use; D013713:Teniposide / Q000627:therapeutic use; D014747:Vinblastine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000077235:Vinorelbine
D009607:Nitrosourea Compounds; D009943:Organophosphorus Compounds; D014747:Vinblastine; D000077146:Irinotecan; D013713:Teniposide; C054368:fotemustine; C040210:edatrexate; D000630:Aminopterin; D017239:Paclitaxel; D000077235:Vinorelbine; D002166:Camptothecin